Loading...
Dapagliflozin
India Pharmaceutical Trade Intelligence
Who Supplies Dapagliflozin to India from UNITED STATES
India's dapagliflozin imports from UNITED STATES total $8057.2B across 184 shipments from 15 foreign suppliers. M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON leads with $8037.5B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ASTRAZENECA PHARMA INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON is the leading Dapagliflozin supplier from UNITED STATES to India, with import value of $8037.5B across 17 shipments. The top 5 suppliers — M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, M S ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, M S ASTRAZENECA PLP MOUNT VERNON, Raff & Hall Pharmacy, M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $8037.5B | 17 | 99.8% |
| 2 | M S ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $18.6B | 4 | 0.2% |
| 3 | M S ASTRAZENECA PLP MOUNT VERNON | $1.1B | 4 | 0.0% |
| 4 | Raff & Hall Pharmacy | $7.4M | 2 | 0.0% |
| 5 | M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $4.1M | 6 | 0.0% |
| 6 | M/S. ASTRAZENECA PLP MOUNT VERNON | $784.6K | 6 | 0.0% |
| 7 | MS ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $508.1K | 3 | 0.0% |
| 8 | M/S. ASTRAZENECA PHARMACEUTICALS PLP MOUNT VERNON | $473.1K | 6 | 0.0% |
| 9 | M/S. ASTRAZENECA PLP MOUNT VERNON | $289.0K | 1 | 0.0% |
| 10 | RAFF & HALL PHARMACY | $137.5K | 11 | 0.0% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC | $80.2K | 12 | 0.0% |
| 12 | GRANULES PHARMACEUTICALS INC | $51.9K | 8 | 0.0% |
| 13 | ESPEE BIOPHARMA & FINECHEM LLC. | $43.8K | 6 | 0.0% |
| 14 | Espee Biopharma & Finechem LLC | $28.4K | 4 | 0.0% |
| 15 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $26.8K | 6 | 0.0% |
Showing top 15 of 15 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASTRAZENECA PHARMA INDIA LIMITED | $8057.2B | 47 | 100.0% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $7.4M | 8 | 0.0% |
| 3 | CIPLA LIMITED | $134.3K | 11 | 0.0% |
| 4 | INVENTIA HEALTHCARE LIMITED | $71.6K | 9 | 0.0% |
| 5 | GRANULES INDIA LIMITED | $51.9K | 8 | 0.0% |
| 6 | USV PRIVATE LIMITED | $48.9K | 6 | 0.0% |
| 7 | EXEMED PHARMACEUTICALS | $24.7K | 6 | 0.0% |
| 8 | HARMAN FINOCHEM LIMITED | $18.0K | 2 | 0.0% |
| 9 | HETERO LABS LIMITED | $17.4K | 5 | 0.0% |
| 10 | WATSON PHARMA PRIVATE LIMITED | $17.1K | 5 | 0.0% |
| 11 | ZYDUS LIFESCIENCES LIMITED | $15.9K | 1 | 0.0% |
| 12 | AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $15.7K | 3 | 0.0% |
| 13 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED | $15.3K | 5 | 0.0% |
| 14 | FDC LIMITED | $15.3K | 3 | 0.0% |
| 15 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $13.6K | 18 | 0.0% |
Import Statistics
- Import Value
- $8057.2B
- Shipments
- 184
- Foreign Suppliers
- 15
- Indian Buyers
- 15
- Avg. Shipment
- $43.8B
Other Dapagliflozin Import Origins
Related Analysis
Frequently Asked Questions — Dapagliflozin Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Dapagliflozin suppliers from UNITED STATES to India?
The top Dapagliflozin suppliers from UNITED STATES to India include M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, M S ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, M S ASTRAZENECA PLP MOUNT VERNON. The leading supplier is M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON with import value of $8037.5B USD across 17 shipments. India imported Dapagliflozin worth $8057.2B USD from UNITED STATES in total across 184 shipments.
QHow much Dapagliflozin does India import from UNITED STATES?
India imported Dapagliflozin worth $8057.2B USD from UNITED STATES across 184 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Dapagliflozin from UNITED STATES?
The main Indian buyers of Dapagliflozin sourced from UNITED STATES include ASTRAZENECA PHARMA INDIA LIMITED, MSN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED. The largest buyer is ASTRAZENECA PHARMA INDIA LIMITED with $8057.2B in imports across 47 shipments.
QWhat is the total value of Dapagliflozin imports from UNITED STATES to India?
The total value of Dapagliflozin imports from UNITED STATES to India is $8057.2B USD, across 184 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Dapagliflozin.
- 2.Supplier/Buyer Matching: 15 foreign suppliers from UNITED STATES and 15 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $8057.2B aggregated from 184 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
184 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists